Evaluation of a computer-assisted antibiotic-dose monitor

Annals of Pharmacotherapy

Volumn 33, Issue 10, 1999, Pages 1026-1031

  Evans, R Scott ^a,b   Pestotnik, Stanley L ^c   Classen, David C ^c   Burke, John P ^c  

^a Medical Informatics   (United States)

^b LDS HOSPITAL   (United States)

^c NONE

Author keywords

Antibiotics; Computers; Epidemiology

Indexed keywords

CEFAZOLIN; CEFUROXIME; GENTAMICIN; IMIPENEM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; COMPUTER ASSISTED THERAPY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG COST; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG THERAPY, COMPUTER-ASSISTED; EVALUATION STUDIES; FEMALE; HOSPITAL INFORMATION SYSTEMS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032832770     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18391     Document Type: Article

References (30)

1. Martone WJ, Jarvis WR, Edwards JR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections. 4rd ed. Philadelphia: Lippincott-Raven Publishers, 1998:461-76.
2. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MS, et al. Trends in infectious disease mortality in the United States. JAMA 1996;275:189-93.
3. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
4. Miwa LJ, Kennedy DL, Freidman JP. US hospital anti-infective use from 1985 to 1990. P & T 1992;17:983-5,989-90,993.
5. Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar E, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989;87:253-9.
6. Kunin CM, Johansen KS, Worning AM, Daschner FD. Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 1990; 12:12-9.
7. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978;275:271-82.
8. McGowan JE. Improving antibiotic use has become essential - can surgery lead the way? Infect Control Hosp Epidemiol 1990;11:575-7.
9. Yu VL, Stoehr GP, Starling RC, Shogan JE. Empiric antibiotic selection by physicians: evaluation of reasoning strategies. Am J Med Sci 1991; 301:165-72.
10. Kunin CM. Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 1993;118:557-61.
11. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
12. Ma MY, Goldstein EJC, Friedman MH, Anderson MS, Mulligan ME. Resistance of g7ram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother 1983;24:347-52.
13. Faich GA. Special report: adverse drug reaction monitoring. N Engl J Med 1986;314:1589-92.
14. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995;274:29-34.
15. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991;266:2847-51.
16. Rawlins MD. Clinical pharmacology: adverse reactions to drugs. Br Med J 1981;282:974-6.
17. Savitsky ME. Recognizing hospital adverse drug reactions. J Pharm Pract 1989;2:203-8.
18. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993;8:289-94.
19. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994;28:523-7.
20. Rind DM, Safran C, Phillips RS, Slack WV, Calkins DR, Delbanco TL, et al. The effect of computer-based reminders on the management of hospitalized patients with worsening renal function. Proc Annu Symp Comput Appl Med Care 1991;15:28-32.
21. Brook RH, Kamberg CJ, McGlynn EA. Health system reform and quality. JAMA 1996;276:476-80.
22. Evans RS, Pestotnik SL, Classen DC, Bass SB, Menlove RL, Gardner RM, et al. Development of a computerized adverse drug event monitor. Proc Annu Symp Comput Appl Med Care 1991;15:23-7.
23. Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP. Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system. Ann Pharmacother 1993;27:497-501.
24. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998:338:232-8.
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
26. Bennett WM, Aronoff GR, Golper TA, Morrision G, Brater DC, Singer I, eds. Drug prescribing in renal failure: dosing guidelines for adults. 3rd rev ed. Philadelphia: American College of Physicians, 1994.
27. Maxwell M, Heaney D, Howie JG, Noble S. General practice fundholding: observation on prescribing patterns and costs using the defined daily dose method [published erratum appears in BMJ 1993:307:1470], BMJ 1993;307:1190-4.
28. The LDS Hospital nurse acuity system. In: Nursing care manual. Salt Lake City, UT, 1996.
29. Classen DC, Pestotnik SL, Evans RS, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997:277:301-6.
30. McDonald CJ. Protocol-based computer reminders, the quality of care and the non-perfectibility of man. N Engl J Med 1976;295:1351-5.